Jon Cohen

Jon R. Cohen, M.D., physician business executive, is Senior Vice President and Group Executive - Diagnostics Solutions for Quest Diagnostics (NYSE: DGX). He is responsible for the Professional Laboratory Services business that manages over 110 hospital/health system laboratories; the Pathology Services, with over 650 employed pathologists; the Oncology and Sports & Human Performance Diagnostics franchises; and for driving growth in Quest’s comprehensive service offerings to hospitals and large health systems. Having spent more than two decades in the healthcare field, Dr. Cohen has extensive operational experience managing large complex organizations in addition to navigating the complex State/Federal healthcare regulatory environment. Dr. Cohen is a vascular surgeon who completed his residency in surgery at New York Presbyterian Hospital/Weill Cornell Medical Center and vascular surgery fellowship at the Brigham and Women's Hospital at Harvard Medical School in Boston. He has published over 100 peer-reviewed professional articles and authored two books. In 2010, he was named as one the nation's top 50 most powerful physician executives by Modern Healthcare. In 2014, his TEDMED “Why Don’t Patients Act Like Consumers?” (2012) was ranked the # 1 TEDMED Ted Talk that every healthcare executive needs to watch.

Quest Diagnostics is the world’s largest diagnostics company with annual revenues of $7.7 billion. Dr. Cohen is one of five executive officers of the corporation, and has P/L responsibility for over $1.2 billion and operational responsibility for the five businesses he leads. He has a successful track record of growing existing business, developing new business ventures and turning around losing entities. He served as the corporation’s Chief Medical Officer from 2009-2015. As CMO, Dr. Cohen was responsible for promoting medical policies that assure the highest possible patient quality and safety; health policies that have the most positive impact on patient care as related to all of Quest's businesses; patient-centric enterprises to align the business towards patient engagement; and broad medical initiatives that leverage the expertise of the medical community of approximately 650 employed physicians and PhDs.

As Director of Hospital Services, Dr. Cohen had P/L and operational responsibility for Quest's second largest line of business. With over $1 billion in revenue, the hospital services line of business encompasses all of the esoteric reference testing that is performed at Quest's four national esoteric laboratories servicing over 3,000 customers worldwide, including hospitals, commercial labs, Department of Defense, Veterans Administration, State and County Departments of Health, Prisons and Indian Services.

After arriving at the Long Island Jewish Medical Center in 1985, Cohen rose through the ranks to become Chief of Vascular Surgery, Chairman of Surgery and Surgeon-in-Chief. As Chief of Vascular Surgery, he built one of the most robust clinical and nationally recognized academic divisions and established the first comprehensive vascular institute in New York. His major research contributions were into the pathophysiology of aortic aneurysm development at the molecular level. Under his leadership as Chairman of Surgery and Surgeon-in-Chief, the department grew to 18 surgeons, with an institutional surgical volume increasing from 17,000 to 25,000 cases per year.

...
Wikipedia